Article History
Accepted: 27 August 2023
First Online: 17 October 2023
Declarations
:
: No funding was received for the preparation of this article.
: Lawrence F. Eichenfield has served as a scientific adviser, consultant, and/or clinical study investigator for Pfizer Inc., AbbVie, Almirall, Amgen, Asana Biosciences, Cutanea, Dermavant, Dermira, Dr.Reddy’s Laboratory, DS Biopharma, Eli Lilly, Forté Pharma, Galderma, Glenmark, Incyte, LEO Pharma, Matrisys Bioscience, Novan, Novartis, Ortho Dermatologics/Valeant, Sanofi Regeneron, Sanofi Genzyme, TopMD, UCB, and Verrica. Erina Lie, Mira Choi, and Sheng-Pei Wang have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors made substantial contributions to the conception or design of the work, revised it critically for important intellectual content, approved the version to be published, and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.